Changing Environments and Alternative Perspectives in Evaluating the Cost-Effectiveness of New Antipsychotic Drugs

The Positive and Negative Syndrome Scale (PANSS) for Schizophrenia

1987 • 19,723 citations

The Brief Psychiatric Rating Scale

1962 • 10,683 citations

ECDEU Assessment Manual for Psychopharmacology

1976 • 8,729 citations

Clozapine for the Treatment-Resistant Schizophrenic

1988 • 4,030 citations

A RATING SCALE FOR EXTRAPYRAMIDAL SIDE EFFECTS

1970 • 3,213 citations

Evaluation: A Systematic Approach

1979 • 3,081 citations

A Rating Scale for Drug-Induced Akathisia

1989 • 2,135 citations

Evaluation: A Systematic Approach

2005 • 1,778 citations

The Quality of Life Scale: An Instrument for Rating the Schizophrenic Deficit Syndrome

1984 • 1,671 citations

Clinical Global Impression

1976 • 1,475 citations

A quality of life interview for the chronically mentally ill

1988 • 1,092 citations

THE BRIEF PSYCHIATRIC RATING SCALE

1962 • 1,091 citations

Sourcebook of criminal justice statistics

2005 • 878 citations

Efficacy and extrapyramidal side-effects of the new antipsychotics olanzapine, quetiapine, risperidone, and sertindole compared to conventional antipsychotics and placebo. A meta-analysis of randomized controlled trials

1999 • 807 citations

Effects of Six Months of Clozapine Treatment on the Quality of Life of Chronic Schizophrenic Patients

1990 • 351 citations

National Institute of Mental Health Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE): Alzheimer Disease Trial Methodology

2001 • 208 citations

Evaluation: A systematic approach, 5th ed.

1993 • 157 citations

Use of Pharmacy Data to Assess Quality of Pharmacotherapy for Schizophrenia in a National Health Care System

2001 • 108 citations

Cost-effectiveness of Clozapine in Patients With High and Low Levels of Hospital Use

1999 • 86 citations

Cost-effectiveness of Clozapine Compared With Conventional Antipsychotic Medication for Patients in State Hospitals

2000 • 86 citations

Continuity of Care, Residence, and Family Burden in Ohio

1994 • 74 citations

Does Participation in Psychosocial Treatment Augment the Benefit of Clozapine?

1998 • 74 citations

From Clinical Trials to Real-World Practice: Use of Atypical Antipsychotic Medication Nationally in the Department of Veterans Affairs

2001 • 65 citations

Review of recent clinical studies with olanzapine

1999 • 61 citations

Comprehensive care of schizophrenia : a textbook of clinical management

2001 • 39 citations

National Institute of Mental Health Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE): Alzheimer Disease Trial Methodology

2001 • 39 citations

Issues in estimating the cost of innovative mental health programs

1995 • 37 citations

Initiating Clozapine Treatment in the Outpatient Clinic: Service Utilization and Cost Trends

1998 • 33 citations

The Effect of Institutional Fiscal Stress on the Use of Atypical Antipsychotic Medications in the Treatment of Schizophrenia

2001 • 30 citations

How transfer payments are treated in cost-effectiveness and cost-benefit analyses

1996 • 19 citations

Abnormal Involuntary Movements

1989 • 18 citations

Abnormal Involuntary Movements

1989 • 2 citations